- Market cap
- Revenue
- Net income
- Cash on hand
- Gross margin
- Net margin
- EPS
- P/E ratio
On March 24th, 2025, Organigram investors approved rebranding from Organigram Holdings to Organigram Global.
In 2023, the company reported a quarterly profit of $5.3 million, reversing a $1.3 million loss a year earlier, as revenue rose to $43.3 million from $30.4 million and margins improved.
In November 2025, the company announced that James Yamanaka, a former executive at British American Tobacco, was being appointed CEO effective around January 15, 2026, and that he would also join the company’s board.